SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000899140-05-000082
Filing Date
2005-02-01
Accepted
2005-02-01 17:15:48
Documents
2
Group Members
STANLEY F. DRUCKENMILLERSTEELER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G d2761010b.txt SC 13G/A 17752
3 JOINT FILING AGREEMENT d2761010c.txt EX-99.1 2462
  Complete submission text file 0000899140-05-000082.txt   21808
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 05566613
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241
Business Address 2579 WASHINGTON ROAD SUITE 322 PITTSBURGH PA 15241 4128543112
DUQUESNE CAPITAL MANAGEMENT L L C (Filed by) CIK: 0001008925 (see all company filings)

IRS No.: 251772402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A